Page last updated: 2024-08-16

sb 206553 and sb 200646a

sb 206553 has been researched along with sb 200646a in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baxter, GS; Blackburn, TP; Booth, DH; Forbes, IT; Glen, A; Ham, P; Kennett, GA; Martin, RT; Thompson, M; Wood, MD1

Other Studies

1 other study(ies) available for sb 206553 and sb 200646a

ArticleYear
5-Methyl-1-(3-pyridylcarbamoyl)-1,2,3,5-tetrahydropyrrolo[2,3-f]indole: a novel 5-HT2C/5-HT2B receptor antagonist with improved affinity, selectivity, and oral activity.
    Journal of medicinal chemistry, 1995, Jul-07, Volume: 38, Issue:14

    Topics: Administration, Oral; Animals; Indoles; Magnetic Resonance Spectroscopy; Mass Spectrometry; Pyridines; Rats; Receptor, Serotonin, 5-HT2B; Receptors, Serotonin; Serotonin Antagonists

1995